India Glycols consolidated net profit rises 36.46% in the December 2024 quarter
05 - Feb - 2025 12:00 | 54 days ago
Net profit of India Glycols rose 36.46% to Rs 56.81 crore in the quarter ended December 2024 as against Rs 41.63 crore during the previous quarter ended December 2023. Sales rose 7.85% to Rs 975.20 crore in the quarter ended December 2024 as against Rs 904.22 crore during the previous quarter ended December 2023.
The company will initially subscribe to 10,000 equity shares at face value of Rs 10 each aggregating to Rs 1,00,000 in cash.
The company will carry on business of spirits and related products.
India Glycols (IGL) manufactures green technology-based bulk, specialty and performance chemicals and natural gums, spirits, industrial gases, sugar and nutraceuticals. IGL operates under three broad segments: bio-based specialities & performance chemicals (BSPC), potable spirits (PS) and ennature biopharma (EB).
The company’s consolidated net profit jumped 30.8% on 24.1% increase in revenue from operations to Rs 961.20 crore in Q2 FY25 over Q2 FY24.
The counter rallied 3.29% to end at Rs 1196.85 on Tuesday, 26 November 2024.
The company will initially subscribe to 10,000 equity shares at face value of Rs 10 each aggregating to Rs 1,00,000 in cash.
The company will carry on business of spirits and related products.
India Glycols (IGL) manufactures green technology-based bulk, specialty and performance chemicals and natural gums, spirits, industrial gases, sugar and nutraceuticals. IGL operates under three broad segments: bio-based specialities & performance chemicals (BSPC), potable spirits (PS) and ennature biopharma (EB).
The company’s consolidated net profit jumped 30.8% on 24.1% increase in revenue from operations to Rs 961.20 crore in Q2 FY25 over Q2 FY24.
The counter rallied 3.29% to end at Rs 1196.85 on Tuesday, 26 November 2024.
India Glycols consolidated net profit rises 36.46% in the December 2024 quarter
05 - Feb - 2025 12:00 | 54 days ago
Net profit of India Glycols rose 36.46% to Rs 56.81 crore in the quarter ended December 2024 as against Rs 41.63 crore during the previous quarter ended December 2023. Sales rose 7.85% to Rs 975.20 crore in the quarter ended December 2024 as against Rs 904.22 crore during the previous quarter ended December 2023.
The company will initially subscribe to 10,000 equity shares at face value of Rs 10 each aggregating to Rs 1,00,000 in cash.
The company will carry on business of spirits and related products.
India Glycols (IGL) manufactures green technology-based bulk, specialty and performance chemicals and natural gums, spirits, industrial gases, sugar and nutraceuticals. IGL operates under three broad segments: bio-based specialities & performance chemicals (BSPC), potable spirits (PS) and ennature biopharma (EB).
The company’s consolidated net profit jumped 30.8% on 24.1% increase in revenue from operations to Rs 961.20 crore in Q2 FY25 over Q2 FY24.
The counter rallied 3.29% to end at Rs 1196.85 on Tuesday, 26 November 2024.
India Glycols consolidated net profit rises 36.46% in the December 2024 quarter
05 - Feb - 2025 12:00 | 54 days ago
Net profit of India Glycols rose 36.46% to Rs 56.81 crore in the quarter ended December 2024 as against Rs 41.63 crore during the previous quarter ended December 2023. Sales rose 7.85% to Rs 975.20 crore in the quarter ended December 2024 as against Rs 904.22 crore during the previous quarter ended December 2023.
The company will initially subscribe to 10,000 equity shares at face value of Rs 10 each aggregating to Rs 1,00,000 in cash.
The company will carry on business of spirits and related products.
India Glycols (IGL) manufactures green technology-based bulk, specialty and performance chemicals and natural gums, spirits, industrial gases, sugar and nutraceuticals. IGL operates under three broad segments: bio-based specialities & performance chemicals (BSPC), potable spirits (PS) and ennature biopharma (EB).
The company’s consolidated net profit jumped 30.8% on 24.1% increase in revenue from operations to Rs 961.20 crore in Q2 FY25 over Q2 FY24.
The counter rallied 3.29% to end at Rs 1196.85 on Tuesday, 26 November 2024.
The company will initially subscribe to 10,000 equity shares at face value of Rs 10 each aggregating to Rs 1,00,000 in cash.
The company will carry on business of spirits and related products.
India Glycols (IGL) manufactures green technology-based bulk, specialty and performance chemicals and natural gums, spirits, industrial gases, sugar and nutraceuticals. IGL operates under three broad segments: bio-based specialities & performance chemicals (BSPC), potable spirits (PS) and ennature biopharma (EB).
The company’s consolidated net profit jumped 30.8% on 24.1% increase in revenue from operations to Rs 961.20 crore in Q2 FY25 over Q2 FY24.
The counter rallied 3.29% to end at Rs 1196.85 on Tuesday, 26 November 2024.
